Bay Harbor Wealth Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
FCM
AIM
AVM
NAMA
Bay Harbor Wealth Management's BEAM Position: Q2 2026 in Review
Bay Harbor Wealth Management held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 2 shares worth $69. The position accounts for ﹤0.01% of the portfolio, ranked #1250.
Bay Harbor Wealth Management first reported a position in BEAM in Q1 2026 and has held it in 2 quarters since. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.
- Bay Harbor Wealth Management held 2 shares of Beam Therapeutics worth $69 as of Q2 2026.
- Bay Harbor Wealth Management left its Beam Therapeutics share count unchanged in Q2 2026.
- Beam Therapeutics made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1250 holding.
- Bay Harbor Wealth Management first reported a position in Beam Therapeutics in Q1 2026 and has held it in 2 quarters since.
- 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.
Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.